World of DTC Marketing

MAY 26, 2021

Today, AbbVie charges approximately $77,000 for a year’s supply of Humira—470% more than when the drug was launched in 2003. Record Corporate Revenue Driven by Price Increases: Since 2003, AbbVie has collected over $107 billion in U.S. The graph below shows AbbVie’s and Amgen’s pricing for Humira and Enbrel from 2003 to 2021.

Competition 180

Competition Marketing Government Patients 180

Eversana Intouch

NOVEMBER 9, 2023

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled.

Pharma 83

Pharma Biopharma Competition Marketing 83

Cesare Ferrari

APRIL 27, 2024

In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. The purpose of this post is to help MedTech professionals to better understand the different types of innovation.

Marketing 52

Marketing Medical Medicine Competition 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The company now faces a highly competitive generics market for its lead drug. Amarin’s net product revenue was $577.9 million in 2021 and $607 million in 2020, as per its financial filings.

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Matrix-assisted laser desorption/ionization analysis of lipids and high molecular weight hydrocarbons with lithium 2,5-dihydroxybenzoate matrix, Rapid Commun Mass Spectrom , 2003; 17, 2203–2207. percent and 7.5=

Electronics 91

Electronics Food Pharmaceutical Doctors 91

Cesare Ferrari

NOVEMBER 6, 2022

In search of a better solution, they began to use manual instruments and surgical drills or competitive products. This group of customers used the previous generation of Medtronic products, but they were not completely satisfied because that product line was unreliable and not very effective. References. Crossing the Chasm. Rogers, E.

Marketing 52

Marketing Sales pitches Sales Media 52

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. The increase, from ASP plus 6% to ASP plus 8%, will last for five years, and may help increase access to and utilization of biosimilars and promote competition in the marketplace.

Marketing 97

Marketing Competition Government Manufacturing 97